lipohypertrophy

Business news, market intelligence, and global industry analysis.

The Latest

Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal

Badger Meter (BMI) adds UK sewer monitoring platform UDlive in $100m expansion move

Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?

What Alamar Biosciences’ (NASDAQ: ALMR) IPO pop says about the next phase of proteomics investing

Neodyne Biosciences and Gan & Lee Pharmaceuticals reveal major clinical advances in diabetes care at ADA 2025

Neodyne Biosciences and Gan & Lee Pharmaceuticals presented major ADA 2025 clinical results showing new treatment paths for lipohypertrophy and type 2 diabetes.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 21, 2025